Portal de Periódicos da CAPES

Anxiety and depression symptoms after virological clearance of COVID‐19: A cross‐sectional study in Milan, Italy

2020; Wiley; Volume: 93; Issue: 2 Linguagem: Inglês

10.1002/jmv.26459

1096-9071

Daniele Tomasoni, Francesca Bai, Roberto Castoldi, Diletta Barbanotti, Camilla Falcinella, Giovanni Mulè, Debora Mondatore, Alessandro Tavelli, Elena Vegni, Giulia Marchetti, Antonella d’Arminio Monforte,

COVID-19 Clinical Research Studies

Prevalence of anxiety or depression was investigated in 105 coronavirus disease 2019 (COVID-19) patients at 1 to 3 months from virological clearance by hospital anxiety and depression scale (HADS-A/D). 30% of patients displayed pathological HADS-A/D, 52.4% showed persistent symptoms. Pathological patients with HADS-A/D more commonly reported symptom persistence, even after adjustment for age, gender, and disease severity. Psychological assessments should be encouraged in COVID-19 patients' follow-up.